Speaking to CNBC-TV18, Sanjay Singhania of EPack Prefab Technologies said the second half of the year is expected to be stronger than the first. The…

Drew Pettit, Director-US Equity Strategy/ETF Analysis & Strategy Research at Citi explains what could drive a re-rating for Indian markets, while outlining why US equities…

Silver prices plunged over 2% on MCX and silver ETFs dropped up to 14% as easing geopolitical tensions and a stronger US dollar prompted investors…

Looking ahead, the company said it expects to exceed its FY26 EBITDA guidance of ₹5,500-6,000 crore.

Oracle Financial’s shares have underperformed over the last 12 months, but the company’s topline growth returned to double digits in the December quarter for the…

The rupee rebounded from its alltime low levels and gained 15 paise to trade at 91.50 against the US dollar in early deals on Thursday,…

Of the 40 analysts tracking Dr Reddy’s Laboratories, 16 have a ‘Buy’ rating, 11 recommend ‘Hold’, while 13 have a ‘Sell’ call.

Despite the weak results, two-thirds of the 34 analysts who have coverage on HPCL have retained their “buy” rating on the stock. Four others have…

Gravita India has targeted over 7 lakh MTPA capacity for the financial year 2028. It has earmarked a capex of over ₹1,500 crore for the…

Apart from issuing bonus shares, eClerx Services has also frequently carried out buybacks of its equity shares, the most recent instances being in December last…